News
--(BUSINESS WIRE)--Blade Therapeutics today announced that it has reached the 120-subject enrollment goal for the Phase 2 clinical study of the Company’s investigational therapeutic, BLD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback